Patents by Inventor Gerald M. Rosen

Gerald M. Rosen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4610806
    Abstract: Fluorescamine or like compounds react with the epidermis when applied to the skin and form, within about 15 to 30 minutes after application to the skin, a long-lasting reaction product, which is invisible in ordinary light but which fluoresces intensely under ultraviolet light. Such markings resist removal by abrasion and repeated washings. Organic solutions of such compounds, preferably containing a fugitive dyestuff or pigment and used as the marking fluid of a conventional felt-tipped pen, can be used to mark skin for radiological or diagnostic purposes. Inanimate objects can be coated with these compounds to detect human contact therewith.
    Type: Grant
    Filed: December 12, 1985
    Date of Patent: September 9, 1986
    Inventor: Gerald M. Rosen
  • Patent number: 4572831
    Abstract: Fluorescamine or like compounds react with the epidermis when applied to the skin and form, within about 15 to 30 minutes after application to the skin, a long-lasting reaction product, which is invisible in ordinary light but which fluoresces intensely under ultraviolet light. Such markings resist removal by abrasion and repeated washings. Organic solutions of such compounds, perferably containing a fugitive dyestuff or pigment and used as the marking fluid of a conventional felt-tipped pen, can be used to mark skin for radiological or diagnostic purposes. Inanimate objects can be coated with these compounds to detect human contact therewith.
    Type: Grant
    Filed: October 19, 1982
    Date of Patent: February 25, 1986
    Inventor: Gerald M. Rosen
  • Patent number: 4520134
    Abstract: N-alkyl-4'-hydroxyacetanilides wherein alkyl is of up to 8 carbon atoms, preferably ethyl or isopropyl, have analgesic, antipyretic, anti-inflammatory and sedative activity. Those of at least two carbon atoms lack the hepatotoxicity of acetaminophen and the N-methyl compound also has substantially less hepatotoxicity than acetaminophen. Pharmaceutical compositions comprising them are employed to ameliorate pain, reduce fever, reduce the symptoms of systemic inflammatory conditions and sedate.
    Type: Grant
    Filed: April 6, 1984
    Date of Patent: May 28, 1985
    Inventor: Gerald M. Rosen
  • Patent number: 4314989
    Abstract: The toxicity in humans of ingested acetaminophen is ameliorated by methionine sulfoxide.
    Type: Grant
    Filed: May 7, 1980
    Date of Patent: February 9, 1982
    Inventor: Gerald M. Rosen